BU BÖLÜM HAKKINDA
In episode 25, host David Willows and producer Sarah Murphy chat about wardrobe options while recording from home (@1:20) before introducing the topic at hand – pharmacare – and their two (virtual) guests (@2:06). First up, David asks first-time guest Chris Bonnett, Principal Consultant at H3 Consulting, about his PhD research topic (@4:34) and the importance of the pharmacare discussion (@9:11). They then talk about what surprised Chris in his research (@12:54), why it appears universal pharmacare isn’t happening (@21:04), and what can be learned from other jurisdictions (@26:36). The discussion wraps with Chris predicting how COVID-19 will impact the pharmacare debate and future public policy (@31:55). Next, David welcomes regular contributor Stephen Frank, CLHIA President and CEO, for a timely check in about the industry (@36:44). David asks Stephen for his views on pharmacare during a COVID, and eventually post-COVID, landscape (@38:37). Stephen then shares why he thinks insurers have fared well from a PR perspective during the pandemic (@45:20) and wraps with thoughts about industry opportunities that have been brought to the foreground (@48:37).
